Colgate-Palmolive delivered a strong start to 2024 with broad-based organic growth across all four categories and six divisions, underscored by a disciplined balance of volume and price. The company reported revenue of $5.07 billion for Q1 2024, up 6% year over year despite a near 4% headwind from foreign exchange, and achieved a gross margin of approximately 60% as price realization and mix mitigated input-cost pressures. Management highlighted investments in advertising and core innovations as key drivers of market share gains, notably in Europe, Latin America, and the North America perimeter where toothpaste and personal care brands gained traction. Free cash flow of $555 million supported a strong capital-allocation framework, including a $509 million share repurchase and continued dividend policy, while maintaining a robust balance sheet with net debt of about $7.61 billion on a total debt of $8.69 billion. Looking forward, Colgate guided to mid- to high-single-digit base business earnings per share (EPS) growth for 2024, anchored by continued revenue-growth management (RGM), Funding-the-Growth (FTG) initiatives, and expanding share in high-priority categories. The quarter also showcased resilience in Hill’s Pet Nutrition, with sequential volume improvement and meaningful pricing that helped offset agricultural input costs. The management team emphasized a return to volume growth, ongoing innovation, and a deliberate approach to advertising ROI as the core to sustaining earnings growth in a volatile macro backdrop.